Back to Search
Start Over
Charge regulated pH/NIR dual responsive nanoplatforms centered on cuproptosis for enhanced cancer theranostics.
- Source :
-
Biomaterials [Biomaterials] 2025 Apr; Vol. 315, pp. 122907. Date of Electronic Publication: 2024 Oct 24. - Publication Year :
- 2025
-
Abstract
- Multifunctional nanoplatforms capable of simultaneously executing multimodal therapy and imaging functions are of great potentials for cancer theranostics. We present an elegantly designed, easy-to-fabricate poly(acrylic acid)/mesoporous calcium phosphate/mesoporous copper phosphate nanosphere (PAA/mCaP/mCuP NS) with outstanding pH/NIR-sensitive multimodal-synergic anti-tumor effects. Optimal porous PAA NS scaffolds were prepared at room temperature by balancing the intra-PAA polymer and polymer-solvents Lennard-Jones potentials in a water:isopropyl alcohol (IPA) mix-solvent. Subsequent sponging of Ca <superscript>2+</superscript> and Cu <superscript>2+</superscript> , and adsorption of PO <subscript>4</subscript> <superscript>3-</superscript> to the PAA template were achieved through exquisite electrostatic interactions among ions and the ionizable PAA side-chain in an aqueous environment. This forms the basis for the tumor microenvironment pH-triggered release of Cu <superscript>2+</superscript> to induce cuproptosis, as well as the photothermal effect originating from CuP, while Ca <superscript>2+</superscript> can enhance the nanoplatform's biocompatibility and can damage mitochondria when overloaded. Lastly, PAA/mCaP/mCuP NSs still exhibit high drug loading efficiency for doxorubicin (DOX), enabling chemotherapy. Satisfactory anti-tumor effects of these modalities, along with their synergistic effects, were verified both in vitro and in vivo, with the NSs demonstrating good biodegradation in the latter. The fabricated NS itself holds great promise as an anti-tumor nanomedicine, and the thorough mechanical insights into NS formation may inspire the design of next-generation multifunctional nanoplatforms.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Subjects :
- Hydrogen-Ion Concentration
Animals
Humans
Mice
Neoplasms therapy
Neoplasms drug therapy
Acrylic Resins chemistry
Mice, Inbred BALB C
Calcium Phosphates chemistry
Nanospheres chemistry
Mice, Nude
Infrared Rays
Cell Line, Tumor
Female
Porosity
Theranostic Nanomedicine methods
Doxorubicin pharmacology
Doxorubicin chemistry
Doxorubicin therapeutic use
Copper chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1878-5905
- Volume :
- 315
- Database :
- MEDLINE
- Journal :
- Biomaterials
- Publication Type :
- Academic Journal
- Accession number :
- 39476451
- Full Text :
- https://doi.org/10.1016/j.biomaterials.2024.122907